Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Huang, Ning
NCT05409547: A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF	Not yet recruiting	4	80	NA	PEG-rhG-CSF, rhG-CSF	Ning Huang	Granulocyte Colony-stimulating Factor, Stem Cell Mobilization	04/25	04/25
NCT06010953: SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment	Completed	1/2	24	RoW	SS109	Jiangsu Gensciences lnc.	Male, Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Hemophilia	05/24	05/24
NCT05651061: A Phase I of SS109 in Hemophilia A or and B With Inhibitors	Completed	1	27	RoW	SS109	Jiangsu Gensciences lnc.	Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency	03/23	08/23
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma	Recruiting	N/A	300	RoW		Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Hepatocellular Carcinoma	03/26	03/26